SCHEMBL4600237

SCHEMBL4600237

COc1ccc(-c2ccc(OC)c(C(=O)O)c2)cc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.60
MAPK1 P28482 1/20 0.60
HTT P42858 1/20 0.60
RAB9A P51151 1/20 0.60
CFD P00746 1/20 0.56
MGLL Q99685 3/20 0.52
JAK2 O60674 1/20 0.52
ERN1 O75460 1/20 0.51
FFAR1 O14842 1/20 0.50
NAAA Q02083 2/20 0.49
AR P10275 1/20 0.49
KDM4E B2RXH2 2/20 0.49
APAF1 O14727 1/20 0.49
RECQL P46063 1/20 0.49
CASP6 P55212 1/20 0.49
CACNA1B Q00975 1/20 0.49
APBA1 Q02410 1/20 0.49
MCL1 Q07820 1/20 0.49
CASP8 Q14790 1/20 0.49
NR1I2 O75469 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21561215 0.90 LMNA (0.60) LMNAMAPK1HTTRAB9ACFD
SCHEMBL2769498 0.89 CFD (0.67) MAPK1RAB9ACFDKDM4EAPAF1
SCHEMBL5154645 0.88 TSHR (0.51) LMNAMAPK1HTTRAB9ACFD
SCHEMBL4600759 0.88 LMNA (0.51) LMNAMAPK1HTTRAB9ACFD
SCHEMBL4602511 0.88 CFD (0.50) LMNAMAPK1HTTRAB9ACFD
SCHEMBL11692501 0.87 CFD (0.56) LMNAMAPK1HTTRAB9ACFD
SCHEMBL12325928 0.85 CFD (0.54) LMNAMAPK1HTTRAB9ACFD
SCHEMBL21857280 0.84 RAB9A (0.54) LMNAMAPK1HTTRAB9AMGLL
SCHEMBL30456866 0.84 CFD (0.50) LMNAMAPK1HTTRAB9ACFD
SCHEMBL25704194 0.84 CFD (0.50) LMNAMAPK1HTTRAB9ACFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R LMNA 3198/4885MAPK1 3998/4885HTT 333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.